An observational study in Acute Conjunctivitis, sponsored by Instituto de Olhos de Goiania. Completed at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2017-11-29.
Sponsored by Instituto de Olhos de Goiania · Observational
Epidemiology of Conjunctivitis in the Emergency Department of a Reference Ophthalmological Hospital in Goiânia.
The purpose of this study was to determine the epidemiology of ocular emergencies in a Reference Ophthalmological Hospital in Goiânia, with emphasis on acute infectious conjunctivitis, morbidity with a higher incidence in this Service. It aims to delineate the main etiologies found among infectious conjunctivitis and to compare them with those found in several other reference services in Ophthalmology.
85 studies on the registry are indexed under Conjunctivitis; 5 are open to participants now.
This study's enrollment of 783 is above the median of 254 across 18 observational studies indexed under Conjunctivitis.
Browse Conjunctivitis studies →Instituto de Olhos de Goiania is the lead sponsor of 27 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients who were submitted to a initial care in the Emergency Department performed by the Ophthalmology First Year Resident (R1) .
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Evaluation of the main etiologies of acute infectious conjunctivitis in the Emergency Department of a Reference Hospital in Goiânia.
Through clinical diagnosis in the Emergency Department
Time frame: 126 days
Ran from May 2017 to primary completion in Sep 2017, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Instituto de Olhos de Goiania